
Camilo Ricordi MD
Director, Diabetes Research Institute and Cell Transplant Center, University of Miami
Join to View Full Profile
1611 NW 12th Ave# M851Miami, FL 33136
Phone+1 305-243-6061
Fax+1 305-243-8470
Dr. Ricordi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Camillo Ricordi, M.D. is Professor of Surgery, Medicine, Biomedical Engineering, Microbiology and Immunology at the University of Miami, Florida, where he serves as Director of the Cell Transplant Center and Director Emeritus of the Diabetes Research Institute
Ricordi has received numerous honors and awards, including the World Prize in Surgery (University of Geneva), the Outstanding Scientific Achievement Award by the American Diabetes Association, was Knighted by the President of the Republic of Italy. He was inducted into the National Academy of Inventors USA, for contributing outstanding inventions that have made a tangible impact on quality of life, economic development, and welfare of society, and was appointed to the Supreme Council of Health (Consiglio Superiore di Sanita’) by the Ministry of Health of Italy. In 2023, he was awarded the Leonardo Da Vinci Award (co-shared with Nobel Prize winners Yamanaka and Semenza - Taormina TaoBuk) and the Venice Golden Lion Award.
Ricordi contributed over 1,170 publications, that received over 54,000 citations, has 115 H-index.
In 2022 he published the best-seller book “IL CODICE DELLA LONGEVITÀ SANA” now available also in its English edition: “THE HEALTHSPAN CODE” (Amazon.com).
Education & Training
- University of Milan Faculty of MedicineClass of 1982
Certifications & Licensure
- FL State Medical License 1996 - 2026
- PA State Medical License 1990 - 2021
Publications & Presentations
PubMed
- Pancreatic β-cell regeneration in situ by the ALK3 agonist THR-123.Silvia Álvarez-Cubela, Isabella D Altilio, Mayur Doke, Dagmar Klein, Alejandro Tamayo
Nature Communications. 2025-07-03 - 1 citationsAdvances in Cell Replacement Therapies for Diabetes.Bernhard J Hering, Michael R Rickels, Melena D Bellin, Jeffrey R Millman, Alice A Tomei
Diabetes... 2025-07-01 - Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.Trevor W Reichman, James F Markmann, Jon Odorico, Piotr Witkowski, John J Fung
The New England Journal of Medicine. 2025-06-20
Press Mentions
- The Miller School at Digestive Disease Week 2025May 22nd, 2025
- Revolutionary Protection for Transplanted CellsNovember 10th, 2024
- UC-MSC Infusions Reduce Risk of Death, Quicken Recovery Time in Severe COVID-19 CasesJanuary 5th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: